Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients

Catheterization and Cardiovascular Interventions

Volumn 58, Issue 4, 2003, Pages 451-454

  Loutfi, Mohamed ^a   Mulvihill, Niall T ^a   Boccalatte, Marco ^a   Farah, Bruno ^a   Fajadet, Jean ^a   Marco, Jean ^a  

^a CLINIQUE PASTEUR   (France)

Author keywords

Atherosclerotic progression; Diabetes millitus; Multivessel stenting; Restenosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; REOPERATION; RESTENOSIS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL RATE;

EID: 0037382142     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10455     Document Type: Article

References (15)

1. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
2. Kip KE, Faxon DP, Detre KM, et al. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute percutaneous stent plus abciximab was approximately half the rate of transluminal coronary angioplasty registry. Circulation 1996;94:1818-1825.
3. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589.
4. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873.
5. BARI investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-1769.
6. King SBI, Kosinski AS, Guyton RA, et al. Eight year mortality in the Emory Angioplasty vs. Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-1121.
7. Serruys PW, Unger F, Sousa JE, et al. Randomized comparison of coronary artery bypass surgery and stenting for the treatment of mul-tivessel disease. N Engl J Med 2001;344:1117-1124.
8. Borst C, Grundeman PF. Minimally invasive coronary artery bypass grafting: an experimental perspective. Circulation 1999;99:1400-1403.
9. Abizaid A, Costa MA, Centermo M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients. Circulation 2001;104:533-538.
10. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994;331:1044-1050.
11. Serruys PW, Foley DP, Jackson G, et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J 1999;20:58-69.
12. Chan AW, Bhatt DL, Sustained benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002;105:691-696.
13. Morice MC, serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
14. Bertrand ME, McFadden EP, Fruchart JC, et al. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty: the PREDICT trial investigators. J Am Coll Cardiol 1997;30:863-869.
15. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty: Lovastatin Restenosis trial study group. N Engl J Med 1994;331:1331-1337.